Close
Smartlab Europe
Achema middle east

Press Releases

Parexel Strengthens Risk-Based Monitoring Offering with CluePoints’ New Advanced Statistical Capabilities

Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative new therapies to improve the world’s health. Announced  its strategic collaboration with CluePoints, an industry-leading provider of Risk-Based Study Execution...

Pharmacosmos A/S announces publication of positive results from the FERWON-NEPHRO study

Pharmacosmos A/S announces publication of positive results from the FERWON-NEPHRO study and the pre-specified pooled safety analyses of the FERWON-NEPHRO and FERWON-IDA studies at the 56th ERA-EDTA congress in Budapest, Hungary. FERWON-NEPHRO is the second trial...

Quanticate Expands Presence in North America with New Toronto Office

Quanticate, a leading global data-focused clinical research organisation(CRO), has announced plans to expand its presence in North America with the opening of a new office in Toronto. Quanticate will deliver statistical consultancy, programming, data management, pharmacovigilance,...

ideaPoint Announces Enhanced Partnering Software and Mobile App at BIO International

Anaqua’s ideaPoint, a leading provider of innovation management solutions, announced the launch of partnering software ideaPoint 5.1 along with Mobile Scout TM v2. The new release gives technology scouts and innovation managers additional tools to discover,...

World Courier and GE Healthcare Collaborate to Drive Commercialization of Cell and Gene Therapies

GE Healthcare and World Courier, a part of AmerisourceBergen, are combining their expertise in manufacturing and logistics to better patient access to cell and gene therapies. Together, they aim to create a seamless end-to-end supply chain...

FDA Approves Galafold for the Treatment of Certain Adult Patients with Fabry Disease

Amicus Therapeutics announced that the U.S. FDA has granted accelerated approval of Galafold™ (migalastat) 123 mg capsules. Galafold is an oral, precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase...

Vetter Works Towards a Sustainable Energy Supply

Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has reached another important milestone regarding sustainability. Beginning immediately, all German sites of the company will be supplied with only CO 2 neutral energy from certified...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »